IBDEI1XF ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34209,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,34209,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,34209,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,34210,0)
 ;;=I08.8^^192^1990^70
 ;;^UTILITY(U,$J,358.3,34210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34210,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,34210,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,34210,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,34211,0)
 ;;=I47.9^^192^1990^63
 ;;^UTILITY(U,$J,358.3,34211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34211,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,34211,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,34211,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,34212,0)
 ;;=I05.1^^192^1990^66
 ;;^UTILITY(U,$J,358.3,34212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34212,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,34212,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,34212,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,34213,0)
 ;;=I05.0^^192^1990^67
 ;;^UTILITY(U,$J,358.3,34213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34213,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,34213,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,34213,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,34214,0)
 ;;=I05.9^^192^1990^68
 ;;^UTILITY(U,$J,358.3,34214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34214,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34214,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,34214,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,34215,0)
 ;;=I21.3^^192^1990^71
 ;;^UTILITY(U,$J,358.3,34215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34215,1,3,0)
 ;;=3^STEMI Myocardial Infarction,Unspec Site
 ;;^UTILITY(U,$J,358.3,34215,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,34215,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,34216,0)
 ;;=I44.30^^192^1990^43
 ;;^UTILITY(U,$J,358.3,34216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34216,1,3,0)
 ;;=3^Atrioventricular Block,Unspec
 ;;^UTILITY(U,$J,358.3,34216,1,4,0)
 ;;=4^I44.30
 ;;^UTILITY(U,$J,358.3,34216,2)
 ;;=^5007204
 ;;^UTILITY(U,$J,358.3,34217,0)
 ;;=I50.40^^192^1990^51
 ;;^UTILITY(U,$J,358.3,34217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34217,1,3,0)
 ;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34217,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,34217,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,34218,0)
 ;;=I50.30^^192^1990^52
 ;;^UTILITY(U,$J,358.3,34218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34218,1,3,0)
 ;;=3^Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34218,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,34218,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,34219,0)
 ;;=I50.20^^192^1990^72
 ;;^UTILITY(U,$J,358.3,34219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34219,1,3,0)
 ;;=3^Systolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34219,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,34219,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,34220,0)
 ;;=I20.0^^192^1990^73
 ;;^UTILITY(U,$J,358.3,34220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34220,1,3,0)
 ;;=3^Unstable Angina
 ;;^UTILITY(U,$J,358.3,34220,1,4,0)
 ;;=4^I20.0
 ;;^UTILITY(U,$J,358.3,34220,2)
 ;;=^5007076
 ;;^UTILITY(U,$J,358.3,34221,0)
 ;;=M32.12^^192^1990^64
 ;;^UTILITY(U,$J,358.3,34221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34221,1,3,0)
 ;;=3^Pericarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,34221,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,34221,2)
 ;;=^5011755
